Search Results
BP Sustainability Guidance – Call for Contributions
The British Pharmacopoeia (BP) is looking for people to help input to the development of sustainability guidance. This guidance is focused on reducing the environmental impacts associated with quality…
Uploaded: 17 August, 2023
Revision to Appendix III, Chromatographic Separation Techniques
test--test…
Uploaded: 9 August, 2023
Working Party BIO-DPS Minutes
BIO-DPS December 2021 BIO-DPS August 2019 BIO-DPS November 2018 BIO-DPS May 2018…
Uploaded: 7 August, 2023
AQbD guidance is now live on BP online
The Analytical Quality by Design (AQbD) supplementary chapter provides best practice guidance on how to enhance method understanding by successfully adopting AQbD concepts in analytical methods. BP…
Uploaded: 2 August, 2023
Apply for a BAN
Applying for a British Approved Name (BAN) involves submitting an application with scientific data as detailed below to the British Pharmacopoeia Secretariat for review and evaluation by expert commit…
Uploaded: 28 July, 2023
About the MHRA
The Medicines and Healthcare products Regulatory Agency (MHRA) is the regulator of medicines, medical devices and blood components for transfusion in the UK. The British Pharmacopoeia Commission (BPC…
Uploaded: 28 July, 2023
How is the BP developed?
New monographs are initiated based on clinical need, risk and usage, developed with key stakeholders and the approved by the British Pharmacopoeia Commission. Monographs are continuously reviewed by s…
Uploaded: 21 July, 2023
Inhaled products
The British Pharmacopoeia (BP) consulted on the BP Commission’s requirements for new and revised monographs for inhalation products. Following the consultation, stakeholder comments were considered by…
Uploaded: 14 July, 2023
Dissolution
The British Pharmacopoeia (BP) consulted on how to improve dissolution testing for solid oral dosage form monographs. Following the consultation, stakeholder comments were considered by the BP Expert…
Uploaded: 14 July, 2023